Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.

Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, Kalimutho M, Sutton CR, Forwood JK, Bert AG, Goodall GJ, Malik L, Yip D, Dahlstrom JE, Zafar A, Khanna KK, Rao S.

Sci Rep. 2019 Dec 5;9(1):18771. doi: 10.1038/s41598-019-55020-1.

2.

Michelin Tire Baby Syndrome: A Rare Case with Review of Literature.

Malik F, Malik L, Aziz S, Ahmed J, Tahir F.

Cureus. 2019 Sep 10;11(9):e5619. doi: 10.7759/cureus.5619.

3.

Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer.

Wu F, McCuaig RD, Sutton CR, Tan AHY, Jeelall Y, Bean EG, Dai J, Prasanna T, Batham J, Malik L, Yip D, Dahlstrom JE, Rao S.

Int J Mol Sci. 2019 Jun 24;20(12). pii: E3080. doi: 10.3390/ijms20123080.

4.

The Impact of Background Music in Reducing Stress During Preclinical Dental Laboratories.

Varma SR, Thomas S, Al Radaideh A, Ergieg S, Fayez E, Malik L.

J Int Soc Prev Community Dent. 2019 Jan-Feb;9(1):77-82. doi: 10.4103/jispcd.JISPCD_258_18. Epub 2019 Feb 14.

5.

Alevin efficiently estimates accurate gene abundances from dscRNA-seq data.

Srivastava A, Malik L, Smith T, Sudbery I, Patro R.

Genome Biol. 2019 Mar 27;20(1):65. doi: 10.1186/s13059-019-1670-y.

6.

Eligibility criteria for phase I clinical trials: tight vs loose?

Malik L, Lu D.

Cancer Chemother Pharmacol. 2019 May;83(5):999-1002. doi: 10.1007/s00280-019-03801-w. Epub 2019 Feb 27. Review.

PMID:
30809701
7.
8.

Increasing complexity in oncology phase I clinical trials.

Malik L, Lu D.

Invest New Drugs. 2019 Jun;37(3):519-523. doi: 10.1007/s10637-018-0699-1. Epub 2018 Nov 16.

PMID:
30443782
9.

Combinatorial Loss of the Enzymatic Activities of Viral Uracil-DNA Glycosylase and Viral dUTPase Impairs Murine Gammaherpesvirus Pathogenesis and Leads to Increased Recombination-Based Deletion in the Viral Genome.

Dong Q, Smith KR, Oldenburg DG, Shapiro M, Schutt WR, Malik L, Plummer JB, Mu Y, MacCarthy T, White DW, McBride KM, Krug LT.

mBio. 2018 Oct 30;9(5). pii: e01831-18. doi: 10.1128/mBio.01831-18.

10.

Optimizing poly (ADP-ribose) polymerase inhibition through combined epigenetic and immunotherapy.

Prasanna T, Wu F, Khanna KK, Yip D, Malik L, Dahlstrom JE, Rao S.

Cancer Sci. 2018 Nov;109(11):3383-3392. doi: 10.1111/cas.13799. Epub 2018 Oct 20. Review.

11.

A comparison of the quality of informed consent for phase I oncology trials over a 30-year period.

Malik L, Cooper J.

Cancer Chemother Pharmacol. 2018 Nov;82(5):907-910. doi: 10.1007/s00280-018-3673-x. Epub 2018 Aug 27.

PMID:
30151620
12.

A phase I pharmacokinetic and pharmacodynamic study of GTI-2040 in combination with gemcitabine in patients with solid tumors.

Malik L, Zwiebel A, Cooper J.

Cancer Chemother Pharmacol. 2018 Sep;82(3):533-539. doi: 10.1007/s00280-018-3647-z. Epub 2018 Jul 18.

PMID:
30022224
13.

Rich Chromatin Structure Prediction from Hi-C Data.

Malik L, Patro R.

IEEE/ACM Trans Comput Biol Bioinform. 2019 Sep-Oct;16(5):1448-1458. doi: 10.1109/TCBB.2018.2851200. Epub 2018 Jun 28.

PMID:
29994683
14.

Grouper: graph-based clustering and annotation for improved de novo transcriptome analysis.

Malik L, Almodaresi F, Patro R.

Bioinformatics. 2018 Oct 1;34(19):3265-3272. doi: 10.1093/bioinformatics/bty378.

PMID:
29746620
15.

Role of immunotherapy in bladder cancer: past, present and future.

Butt SU, Malik L.

Cancer Chemother Pharmacol. 2018 Apr;81(4):629-645. doi: 10.1007/s00280-018-3518-7. Epub 2018 Jan 24. Review.

PMID:
29368051
16.

LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.

Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, Kalimutho M, Sutton CR, Forwood JK, Bert AG, Goodall GJ, Malik L, Yip D, Dahlstrom JE, Zafar A, Khanna KK, Rao S.

Sci Rep. 2018 Jan 8;8(1):73. doi: 10.1038/s41598-017-17913-x. Erratum in: Sci Rep. 2019 Dec 5;9(1):18771.

17.

Assessing tether anchor labeling and usability in pickup trucks.

Klinich KD, Manary MA, Malik LA, Flannagan CA, Jermakian JS.

Traffic Inj Prev. 2018 Apr 3;19(3):287-291. doi: 10.1080/15389588.2017.1383986. Epub 2018 Mar 1.

PMID:
29083943
18.

Protective Effects of Nigella Sativaon Acetylsalicylic Acid-Induced Nephrotoxicity in Albino Rats.

Asif S, Malik L.

J Coll Physicians Surg Pak. 2017 Sep;27(9):536-539. doi: 2694.

PMID:
29017666
19.

RTA Occupancy of the Origin of Lytic Replication during Murine Gammaherpesvirus 68 Reactivation from B Cell Latency.

Santana AL, Oldenburg DG, Kirillov V, Malik L, Dong Q, Sinayev R, Marcu KB, White DW, Krug LT.

Pathogens. 2017 Feb 16;6(1). pii: E9. doi: 10.3390/pathogens6010009.

20.

Fulminant but Not Fatal.

Duong TN, Malik L, Venugopal S, Amsterdam EA.

Am J Med. 2016 Jul;129(7):e47-9. doi: 10.1016/j.amjmed.2016.02.050. Epub 2016 Apr 11. No abstract available.

PMID:
27080444
21.

Advanced Cancer Patients' Understanding and Perceptions of Phase I Clinical Trials.

Pawlowski J, Malik L, Mahalingam D.

Cancer Invest. 2015;33(10):490-5. doi: 10.3109/07357907.2015.1069833. Epub 2015 Oct 13.

PMID:
26460889
22.

A de Novo-Designed Monomeric, Compact Three-Helix-Bundle Protein on a Carbohydrate Template.

Malik L, Nygaard J, Cristensen NJ, Madsen CS, Rösner HI, Kragelund BB, Hoiberg-Nielsen R, Streicher WW, Arleth L, Thulstrup PW, Jensen KJ.

Chembiochem. 2015 Sep 7;16(13):1905-1918. doi: 10.1002/cbic.201500285. Epub 2015 Aug 14.

PMID:
26147795
23.

Chagas Heart Disease: An Update.

Malik LH, Singh GD, Amsterdam EA.

Am J Med. 2015 Nov;128(11):1251.e7-9. doi: 10.1016/j.amjmed.2015.04.036. Epub 2015 Jun 4. Review.

PMID:
26052027
24.

Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

Constantino JN, Zhang Y, Holzhauer K, Sant S, Long K, Vallorani A, Malik L, Gutmann DH.

J Pediatr. 2015 Sep;167(3):621-6.e1. doi: 10.1016/j.jpeds.2015.04.075. Epub 2015 Jun 4.

25.

The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease.

Malik LH, Singh GD, Amsterdam EA.

Clin Cardiol. 2015 Sep;38(9):565-9. doi: 10.1002/clc.22421. Epub 2015 May 21. Review.

26.

[Bilateral ureterocele in adult--a case report and review of literature].

Cichoń W, Malik L, Maciukiewicz P, Kotuła J.

Przegl Lek. 2014;71(8):460-1. Review. Polish.

PMID:
25546921
27.

Factors affecting tether use and correct use in child restraint installations.

Jermakian JS, Klinich KD, Orton NR, Flannagan CA, Manary MA, Malik LA, Narayanaswamy P.

J Safety Res. 2014 Dec;51:99-108. doi: 10.1016/j.jsr.2014.09.011. Epub 2014 Oct 7.

PMID:
25453183
28.

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors.

Mahalingam D, Nemunaitis JJ, Malik L, Sarantopoulos J, Weitman S, Sankhala K, Hart J, Kousba A, Gallegos NS, Anderson G, Charles J, Rogers JM, Senzer NN, Mita AC.

Cancer Chemother Pharmacol. 2014 Dec;74(6):1241-50. doi: 10.1007/s00280-014-2602-x. Epub 2014 Oct 11.

PMID:
25304209
29.

Predicting success in regulatory approval from Phase I results.

Malik L, Mejia A, Parsons H, Ehler B, Mahalingam D, Brenner A, Sarantopoulos J, Weitman S.

Cancer Chemother Pharmacol. 2014 Nov;74(5):1099-103. doi: 10.1007/s00280-014-2596-4. Epub 2014 Sep 23.

30.

Eligibility of patients with renal impairment for Phase I trials: Time for a rethink?

Malik L, Mejia A, Weitman S.

Eur J Cancer. 2014 Nov;50(17):2893-6. doi: 10.1016/j.ejca.2014.09.001. Epub 2014 Sep 17.

PMID:
25241228
31.

How well informed is the informed consent for cancer clinical trials?

Malik L, Kuo J, Yip D, Mejia A.

Clin Trials. 2014 Dec;11(6):686-8. doi: 10.1177/1740774514548734. Epub 2014 Aug 18.

PMID:
25135910
32.

Treating breast cancer with trabectedin: a new arsenal.

Malik L.

Ann Oncol. 2014 Oct;25(10):2094-5. doi: 10.1093/annonc/mdu262. Epub 2014 Jul 23. No abstract available.

33.

Cervical cancer: is the wall crumbling?

Malik L, Mejia AV.

Cancer. 2014 Nov 15;120(22):3585-6. doi: 10.1002/cncr.28916. Epub 2014 Jul 16. No abstract available.

34.

Decreased toxicity with 2 weeks on and 1 week off schedule of sunitinib in metastatic renal cell carcinoma: is it a mirage or an oasis?

Malik L.

Eur J Cancer. 2014 Aug;50(12):2171-2. doi: 10.1016/j.ejca.2014.05.014. Epub 2014 Jun 12. No abstract available.

PMID:
24930626
35.

The dilemmas of breast cancer treatment and increased fracture risk.

Malik L.

Ann Oncol. 2014 Aug;25(8):1664. doi: 10.1093/annonc/mdu219. Epub 2014 Jun 11. No abstract available.

36.

Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.

Mahalingam D, Malik L, Beeram M, Rodon J, Sankhala K, Mita A, Benjamin D, Ketchum N, Michalek J, Tolcher A, Wright J, Sarantopoulos J.

Cancer Chemother Pharmacol. 2014 Jul;74(1):77-84. doi: 10.1007/s00280-014-2479-8. Epub 2014 May 10.

PMID:
24817603
37.

Informed consent for phase I oncology trials: form, substance and signature.

Malik L, Mejia A.

J Clin Med Res. 2014 Jun;6(3):205-8. doi: 10.14740/jocmr1803w. Epub 2014 Mar 31.

38.

T-wave tease: apical hypertrophic cardiomyopathy.

Malik LH, Singh GD, Amsterdam EA.

Am J Med. 2014 Jun;127(6):498-500. doi: 10.1016/j.amjmed.2014.02.028. Epub 2014 Mar 6. No abstract available.

PMID:
24608023
39.

Relationship between stress and coronary heart disease.

Kurd BJ, Dar MI, Shoaib M, Malik L, Aijaz Z, Asif I.

Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):142-7. doi: 10.1177/0218492312469803. Epub 2013 Jul 16.

PMID:
24585783
40.

Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials.

Malik L, Parsons H, Mahalingam D, Ehler B, Goros M, Mejia A, Brenner A, Sarantopoulos J.

Clin Genitourin Cancer. 2014 Oct;12(5):359-65. doi: 10.1016/j.clgc.2014.01.011. Epub 2014 Feb 4.

41.

Case of single right atrial diverticulum and review of etiology and management.

Borgohain S, Malik L, Prasad S, Gupta A, Grover V, Gupta VK.

Asian Cardiovasc Thorac Ann. 2013 Oct;21(5):592-5. doi: 10.1177/0218492312458787. Epub 2013 Jul 1. Review.

PMID:
24570563
42.

Left atrial appendage myxoma masquerading as left atrial appendage thrombus.

Malik L, Borgohain S, Gupta A, Grover V, Gupta VK.

Asian Cardiovasc Thorac Ann. 2013 Apr;21(2):205-7. doi: 10.1177/0218492312450019.

PMID:
24532623
43.

Effect of a single finnish sauna session on white blood cell profile and cortisol levels in athletes and non-athletes.

Pilch W, Pokora I, Szyguła Z, Pałka T, Pilch P, Cisoń T, Malik L, Wiecha S.

J Hum Kinet. 2013 Dec 31;39:127-35. doi: 10.2478/hukin-2013-0075. eCollection 2013 Dec 18.

44.

Advanced Thyroid Cancer Patients in Phase I Clinical Trials: Outcome Assessment and Literature Review.

Malik L, Mejia A.

World J Oncol. 2014 Feb;5(1):24-32. doi: 10.14740/wjon768w. Epub 2014 Mar 11.

45.

Pandora box opened--measles unleashed in Pakistan!

Khan AW, Ghani A, Malik L.

J Pak Med Assoc. 2013 Oct;63(10):1328. No abstract available.

46.

Single institutional series of neuroendocrine tumors managed in the Australian Capital Territory.

Malik L, Chua YJ, Butt NS, Yip D.

Asia Pac J Clin Oncol. 2016 Mar;12(1):e133-40. doi: 10.1111/ajco.12121. Epub 2013 Oct 24.

PMID:
24164683
47.

Metastatic gastrointestinal stromal tumour of the ileum with dual primary c-KIT missence mutations.

Malik L, Hemmings C, Beshay V, Fox S, Yip D.

Pathology. 2013 Oct;45(6):604-6. doi: 10.1097/PAT.0b013e3283653792. No abstract available.

PMID:
24018806
48.

Microwave-assisted solid-phase peptide synthesis using the biotage Syro Wave™.

Malik L, Jensen KJ.

Methods Mol Biol. 2013;1047:225-34. doi: 10.1007/978-1-62703-544-6_16.

PMID:
23943490
49.

Effects of child restraint system features on installation errors.

Klinich KD, Manary MA, Flannagan CA, Ebert SM, Malik LA, Green PA, Reed MP.

Appl Ergon. 2014 Mar;45(2):270-7. doi: 10.1016/j.apergo.2013.04.005. Epub 2013 May 31.

PMID:
23731627
50.

Self-assembly of designed coiled coil peptides studied by small-angle X-ray scattering and analytical ultracentrifugation.

Malik L, Nygaard J, Christensen NJ, Streicher WW, Thulstrup PW, Arleth L, Jensen KJ.

J Pept Sci. 2013 May;19(5):283-92. doi: 10.1002/psc.2497. Epub 2013 Mar 17.

PMID:
23505212

Supplemental Content

Support Center